MENU

Regeneron Pharmaceuticals (REGN) Earnings Date & Reports

Industry: @Biotechnology
A.I. Advisor
published Earnings

REGN is expected to report earnings to rise 10.99% to $10.60 per share on August 01

Regeneron Pharmaceuticals REGN Stock Earnings Reports
Q2'24
Est.
$10.60
Q1'24
Missed
by $0.64
Q4'23
Beat
by $1.09
Q3'23
Beat
by $0.91
Q2'23
Beat
by $0.39
The last earnings report on May 02 showed earnings per share of $9.55, missing the estimate of $10.19. With 306.24K shares outstanding, the current market capitalization sits at 116.31B.
View a ticker or compare two or three
REGN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of medicines for the treatment of serious medical conditions

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
777 Old Saw Mill River Road
Phone
+1 914 847-7000
Employees
13450
Web
https://www.regeneron.com